Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer

详细信息    查看全文

• 作者：Divya Pathania ; Mario Sechi ; Michele Palomba ; Vanna Sanna ; Francesco Berrettini ; Angela Sias ; Laleh Taheri ; Nouri Neamati
• 关键词：CMFDA ; 5-chloromethylfluorescein diacetate ; DMEM ; Dulbecco's Modified Eagle Medium ; DMSO ; dimethyl sulfoxide ; DNA ; deoxyribonucleic acid ; DPBS ; Dulbecco's Phosphate Buffered Saline ; DRAQ5® ; 1 ; 5-bis{[2-(di-methylamino) ethyl]amino}-4 ; 8-dihydroxyanthracene-9 ; 10-dione ; EDTA ; ethylene diaminetetraacetic acid ; FoxO3a ; forkhead box transcription factor 3a ; GAPDH ; glyceraldehyde 3-phosphate dehydrogenase ; GSH ; glutathione (reduced) ; JNK ; c-Jun N-terminal kinase ; MnSOD ; manganese superoxide dismutas
• 刊名：Biochimica et Biophysica Acta (BBA)/General Subjects
• 出版年：January, 2014
• 年：2014
• 卷：1840
• 期：1
• 页码：332-343
• 全文大小：2518 K

文摘

Background

Altered cellular bioenergetics and oxidative stress are emerging hallmarks of most cancers including pancreatic cancer. Elevated levels of intrinsic reactive oxygen species (ROS) in tumors make them more susceptible to exogenously induced oxidative stress. Excessive oxidative insults overwhelm their adaptive antioxidant capacity and trigger ROS-mediated cell death. Recently, we have discovered a novel class of quinazolinediones that exert their cytotoxic effects by modulating ROS-mediated signaling.

Methods

Cytotoxic potential was determined by colorimetric and colony formation assays. An XF24 Extracellular Flux Analyzer, and colorimetric and fluorescent techniques were used to assess the bioenergetics and oxidative stress effects, respectively. Mechanism was determined by Western blots.

Results

Compound 3a (6-[(2-acetylphenyl)amino]quinazoline-5,8-dione) was identified through a medium throughput screen of ~ 1000 highly diverse in-house compounds and chemotherapeutic agents for their ability to alter cellular bioenergetics. Further structural optimizations led to the discovery of a more potent analog, 3b (6-[(3-acetylphenyl)amino]quinazoline-5,8-dione) that displayed anti-proliferative activities in low micromolar range in both drug-sensitive and drug-resistant cancer cells. Treatment with 3b causes Akt activation resulting in increased cellular oxygen consumption and oxidative stress in pancreatic cancer cells. Moreover, oxidative stress induced by 3b promoted activation of stress kinases (p38/JNK) resulting in cancer cell death. Treatment with antioxidants was able to reduce cell death confirming ROS-mediated cytotoxicity.

Conclusion

In conclusion, our novel quinazolinediones are promising lead compounds that selectively induce ROS-mediated cell death in cancer cells and warrant further preclinical studies.

General significance

Since 3b (6-[(3-acetylphenyl)amino]quinazoline-5,8-dione) exerts Akt-dependent ROS-mediated cell death, it might provide potential therapeutic options for chemoresistant and Akt-overexpressing cancers.